Individualizing Systemic Therapy Strategies in Prostate CancerSent on 23 June 2026
Optimizing PSMA Radioligand Therapy in Advanced Prostate CancerSent on 22 June 2026
Individualizing Treatment Intensification in mHSPCSent on 21 June 2026
Evolving Strategies in Localized Prostate Cancer: Treatment Intensification, Imaging, and Risk StratificationSent on 19 June 2026
Biomarkers, EZH2 Targeting, and Treatment Selection in Advanced Prostate CancerSent on 17 June 2026
UroAlerts - Prostate Cancer WeeklySent on 16 June 2026
From Mechanism to Practice: Radiopharmaceutical Therapy in Prostate CancerSent on 16 June 2026
FDA Approval in PTEN-Deficient Androgen Pathway Modulation-Naïve or -Sensitive Prostate CancerSent on 12 June 2026
Patient Selection, Imaging, and Sequencing in PSMA-Targeted Prostate Cancer CareSent on 11 June 2026
Investigational Approaches in Advanced Prostate CancerSent on 10 June 2026
UroAlerts - Prostate Cancer WeeklySent on 09 June 2026
UroAlerts - Prostate Cancer WeeklySent on 02 June 2026
ASCO 2026 Radioligand Therapy Advances Across Prostate CancerSent on 02 June 2026
ASCO 2026 Prostate Cancer Advances Across the Disease ContinuumSent on 01 June 2026
Key Prostate Cancer Insights From Day 3 at ASCOSent on 31 May 2026
ASCO 2026 Matching Prostate Cancer Treatment to Risk, Response, and Patient BenefitSent on 31 May 2026
Navigating Treatment Decisions as Prostate Cancer ProgressesSent on 28 May 2026
Emerging Strategies Shaping PSMA-Directed Prostate Cancer CareSent on 27 May 2026
UroAlerts - Prostate Cancer WeeklySent on 26 May 2026
Key GU Oncology Data to Watch at ASCO 2026Sent on 26 May 2026
Treatment Intensification, Monitoring, and Emerging Therapies in Prostate CancerSent on 24 May 2026
UroAlerts - Prostate Cancer WeeklySent on 19 May 2026
AUA 2026 Highlights Evolving Strategies in Prostate Cancer CareSent on 16 May 2026
Understanding Radiopharmaceutical Therapy in Prostate Cancer: From Mechanism to Clinical PracticeSent on 14 May 2026
Key Bladder and Prostate Cancer Data to Watch at AUA 2026Sent on 13 May 2026
UroAlerts - Prostate Cancer WeeklySent on 12 May 2026
Overcoming Resistance in Advanced Prostate CancerSent on 07 May 2026
Optimizing Radioligand Therapy for Advanced Prostate CancerSent on 06 May 2026
Refining Treatment Selection Across Advanced Prostate CancerSent on 05 May 2026
UroAlerts - Prostate Cancer WeeklySent on 05 May 2026
Optimizing Long-Term Management in Advanced Prostate CancerSent on 04 May 2026
APCCC 2026 Closing Gaps in Precision Prostate Cancer CareSent on 02 May 2026
APCCC 2026 Session 3 Highlights Rethinking Treatment Strategy in mHSPCSent on 01 May 2026
APCCC 2026 Session 1 Highlights: Matching Treatment Intensity to Risk in Prostate CancerSent on 30 April 2026
Managing High-Risk Biochemical Recurrence Before Metastatic ProgressionSent on 29 April 2026
UroAlerts - Prostate Cancer WeeklySent on 28 April 2026
Using PSMA PET to Guide Care in nmCRPCSent on 27 April 2026
How AI and Genomics Are Changing Prostate Cancer CareSent on 24 April 2026
Defining Progression and Response in Advanced Prostate CancerSent on 23 April 2026
Translating Emerging Science into Prostate Cancer CareSent on 22 April 2026
UroAlerts - Prostate Cancer WeeklySent on 21 April 2026
Targeting Epigenetics and Advancing Precision Care in Prostate CancerSent on 21 April 2026
Balancing Efficacy and Toxicity in Advanced Prostate Cancer CareSent on 17 April 2026
Balancing Treatment Intensification and Quality of Life in mHSPCSent on 16 April 2026
Advancing Decision-Making Across Localized Prostate Cancer CareSent on 15 April 2026
UroAlerts - Prostate Cancer WeeklySent on 14 April 2026
Refining Treatment Strategies in Biochemical RecurrenceSent on 13 April 2026
From Biology to Biomarkers Advancing Precision in Prostate CancerSent on 11 April 2026
Biomarker-Guided Treatment Decisions in mHSPCSent on 08 April 2026
UroAlerts - Prostate Cancer WeeklySent on 07 April 2026
  • Page of 47
Display #
Results 1 - 50 out of 2313